Rare
lephants
Screener
Toggle theme
Scilex Holding Company
SCLXW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
Total Cash from Operations:
$19.7M
Line Item
Value
% of Total
Other Investing
$2.5M
12.6%
Dividends Paid
$0
0.0%
Other Financing
$0
0.0%
Working Capital
$386.0K
2.0%
Other
$16.9M
85.4%
Net Cash Flow
$0
0.0%
Download CSV
